Septerna (SEPN) Income towards Parent Company (2023 - 2026)

Septerna (SEPN) recorded quarterly Income towards Parent Company of -$8.6 million in Q1 2026, up 19.57% quarter-over-quarter from -$10.7 million in Q4 2025, and up 59.78% on a YoY basis from -$5.4 million in Q1 2025.

Septerna (SEPN) Income towards Parent Company (2023 - 2026) Analysis & Trends

Septerna's Income towards Parent Company history runs 4 years deep, the most recent figure standing at -$8.6 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 59.78% year-over-year to -$8.6 million; the TTM figure through Mar 2026 stood at -$36.0 million (up 54.57% YoY), while the FY2025 annual figure was -$48.9 million, up 31.92% from the prior year.
  • Income towards Parent Company was -$8.6 million for Q1 2026 at Septerna, up from -$10.7 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $8.2 million in Q3 2025 to a low of -$24.8 million in Q2 2025.
  • Historically, Income towards Parent Company has averaged -$14.4 million across 4 years, with a median of -$16.7 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company sank 87.51% in 2024, then soared 139.82% in 2025.
  • A 4-year view of Income towards Parent Company shows it stood at -$18.2 million in 2023, then slipped by 13.85% to -$20.7 million in 2024, then jumped by 48.05% to -$10.7 million in 2025, then rose by 19.57% to -$8.6 million in 2026.
  • The last three Income towards Parent Company figures came in at -$8.6 million (Q1 2026), -$10.7 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Septerna 1.62 Bn 1.62 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.64 Mn
Dec 31, 2025 -10.74 Mn
Sep 30, 2025 8.17 Mn
Jun 30, 2025 -24.84 Mn
Mar 31, 2025 -21.48 Mn
Dec 31, 2024 -20.67 Mn
Sep 30, 2024 -20.52 Mn
Jun 30, 2024 -16.66 Mn
Mar 31, 2024 -14.35 Mn
Dec 31, 2023 -18.15 Mn
Sep 30, 2023 -10.95 Mn